Introduction: Anti-vascular endothelial growth factor (VEGF) therapy has become the most
commonly used treatment for macular edema secondary to retinal vein occlusion (RVO) …

The high prevalence of cardiovascular disease particularly in the elderly population is
associated with retinal vascular disease. Retinal vein occlusions represent severe …

Thrombosis of retinal veins is one of the most common retinal vascular diseases that may
lead to vascular blindness. The latest epidemiological data leave no illusions that the …

Background: Retinal vein occlusion (RVO) occurs when there is partial or complete
obstruction of a retinal vein, and it is classified by the location of the occlusion. An …

Purpose To evaluate spectral-domain (SD)-OCT features associated with baseline vision
and visual outcomes in the prospective, multicenter Study Evaluating Dosing Regimens for …

Purpose Dual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers
excellent visual acuity gains with strong durability in patients with diabetic macular edema …

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

Aim To objectively assess disease activity and treatment response in patients with retinal
vein occlusion (RVO), neovascular age-related macular degeneration (nAMD) and centre …

This review assessed the real-world evidence of the management of macular oedema
secondary to branch retinal vein occlusion (BRVO). A meta-analysis of 2530 eyes from 48 …

Black phosphorus quantum dots (BPQDs) have shown potential in tumor therapy, however,
their anti-angiogenic functions have not been studied. Although BPQDs are easily degraded …